The emergence of single cell transcriptomics (vs. transcriptomic studies that measure tumors in bulk) has refined the molecular signatures of tumor cells and different stromal cell populations thus providing a closer look at FN expression and function in different cell types, and across cancer types. The gene discussed is FN1; the disease is neoplasm.